Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences